Evidence map›Paper›PMID 23615906›Full record

ArticleThe Journal of biological chemistry2013

Endoplasmic reticulum glycoprotein quality control regulates CD1d assembly and CD1d-mediated antigen presentation.

Amit Kunte, Wei Zhang, Crina Paduraru, Natacha Veerapen, Liam R Cox, Gurdyal S Besra, Peter Cresswell

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Amit KunteSection of Infectious Diseases, Department of Internal Medicine, New Haven, Connecticut 06520-8011.
Wei ZhangDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520-8011.
Crina PaduraruDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520-8011.
Natacha VeerapenSchool of Biosciences, Edgbaston, Birmingham B15 2TT, United Kingdom.
Liam R CoxSchool of Chemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
Gurdyal S BesraSchool of Biosciences, Edgbaston, Birmingham B15 2TT, United Kingdom.
Peter CresswellDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520-8011. Electronic address: peter.cresswell@yale.edu.
Howard Hughes Medical Institute · USThe Edgbaston Hospital · GBUniversity of Birmingham · GBYale University · US

Funding

Molecular Aspects of Human CD1d FunctionsR01AI059167 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2004 to 2019
$5.6M
Howard Hughes Medical InstituteMedical Research Council G1001750NIAID NIH HHS R01 AI059167NIAID NIH HHS R01-AI059167Wellcome Trust 084923/B/08/Z
6 · The paper itself

Abstract

The non-classical major histocompatibility complex (MHC) homologue CD1d presents lipid antigens to innate-like lymphocytes called natural-killer T (NKT) cells. These cells, by virtue of their broad cytokine repertoire, shape innate and adaptive immune responses. Here, we have assessed the role of endoplasmic reticulum glycoprotein quality control in CD1d assembly and function, specifically the role of a key component of the quality control machinery, the enzyme UDP glucose glycoprotein glucosyltransferase (UGT1). We observe that in UGT1-deficient cells, CD1d associates prematurely with β2-microglobulin (β2m) and is able to rapidly exit the endoplasmic reticulum. At least some of these CD1d-β2m heterodimers are shorter-lived and can be rescued by provision of a defined exogenous antigen, α-galactosylceramide. Importantly, we show that in UGT1-deficient cells the CD1d-β2m heterodimers have altered antigenicity despite the fact that their cell surface levels are unchanged. We propose that UGT1 serves as a quality control checkpoint during CD1d assembly and further suggest that UGT1-mediated quality control can shape the lipid repertoire of newly synthesized CD1d. The quality control process may play a role in ensuring stability of exported CD1d-β2m complexes, in facilitating presentation of low abundance high affinity antigens, or in preventing deleterious responses to self lipids.

Indexed as

AnimalsAntigen PresentationAntigens, CD1dbeta 2-MicroglobulinCell LineEndoplasmic ReticulumGlucosyltransferasesMiceMice, Mutant StrainsProtein MultimerizationProtein StabilityProtein TransportAntigens, CD1dbeta 2-MicroglobulinCd1d1 protein, mouseGlucosyltransferasesAntigen ProcessingER Quality ControlMajor Histocompatibility Complex (MHC)T cellTransport

Identifiers

PMID23615906
PMCPMC3675576
OpenAlexW2040012723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.